SZM679 is a RIPK1 inhibitor that has potential to serve as an agent for improving cognitive function in the treatment of Alzheimer's disease. SZM679 was found to reverse tumor necrosis factor-induced systemic inflammatory response syndrome, improve learning, memory dysfunction, and neuronal loss, and shows promise for the future development of novel anti-AD agents.
MedKoo Cat#: 130145
Name: SZM679
CAS#: N/A
Chemical Formula: C27H18F5N3O5S
Exact Mass: 591.0887
Molecular Weight: 591.51
Elemental Analysis: C, 54.83; H, 3.07; F, 16.06; N, 7.10; O, 13.52; S, 5.42
The following data is based on the product molecular weight 591.51 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |